title: Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
authors.forename: M
authors.initials: M
authors.lastname: Penz
authors.forename: G V
authors.initials: GV
authors.lastname: Kornek
authors.forename: M
authors.initials: M
authors.lastname: Raderer
authors.forename: H
authors.initials: H
authors.lastname: Ulrich-Pur
authors.forename: W
authors.initials: W
authors.lastname: Fiebiger
authors.forename: W
authors.initials: W
authors.lastname: Scheithauer
mesh_terms: D000328:Adult; D000368:Aged; D004999:Amifostine / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000077150:Oxaliplatin; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D010865:Pilot Projects; D011837:Radiation-Protective Agents / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011837:Radiation-Protective Agents; D000077150:Oxaliplatin; D004999:Amifostine